Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
2
33%
Ph phase_3
2
33%
Ph phase_4
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 32 (33.3%)
Phase 41 (16.7%)

Trials by Status

completed467%
terminated117%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_2

A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection

NCT04847440
completedphase_3

Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients

NCT02967939
completedphase_2

REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection

NCT02565719
unknownphase_3

Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet

NCT02805738
completedphase_4

Safety Study of Once a Day ART and Opiate Substitute.

NCT00324688
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04847440Phase 2

A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection

Terminated
NCT02967939Phase 3

Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients

Completed
NCT02565719Phase 2

REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection

Completed
NCT02805738Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet

Unknown
NCT00324688Phase 4

Safety Study of Once a Day ART and Opiate Substitute.

Completed
NCT01080820Phase 1

A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6